Pharma Merger Mania Continues: Thermo Fisher Offers $7.2 Billion for Patheon

SUGAR LAND--May 17, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The Pharmaceutical-Biotech Industry merger and acquisition mania continues with Thermo Fisher Scientific's (NYSE:TMO) (Waltham, Massachusetts) $7.2 billion offer to acquire Patheon N.V (NYSE:PTHN) (Amsterdam, The Netherlands), a leading contract development and manufacturing organization (CDMO).

Within this article: Details on how the acquisition could change the landscape for pharmaceuticals.